Zealand Pharma A/S | ZEAL - Operating Expenses


Zealand Pharma A/S reported 573M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Akebia Therapeutics USD 63.08M 8.26M Dec/2025
Alaunos Therapeutics USD 952K 60K Jun/2026
Avita Medical AUD 28.56M 534K Jun/2026
Dianthus Therapeutics USD 62.24M 15.25M Jun/2026
Ionis Pharmaceuticals USD 370.24M 6.24M Jun/2026
IQVIA Holdings USD 3.82B 2.05B Sep/2026
Moderna USD 1.18B 223M Sep/2026
Organon & Co USD 1.19B 187M Sep/2026
Revvity USD 604.27M 719K Sep/2026
Tectonic Therapeutic USD 24.22M 3.08M Jun/2026
Tilray USD 237.52M 17.34M Sep/2025
Viatris USD 3.49B 189.1M Sep/2026
Xeris Pharmaceuticals USD 86.93M 11.72M Jun/2026
Zealand Pharma A/S 573M 202.97M Mar/2026